1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Minimally-invasive diagnosis of diffuse leptomeningeal glioneuronal tumor (DLGNT) using cerebrospinal fluid cell-free DNA sequencing in pediatric and young adult patients
    Meeting Abstract

    Larsen, A. G.; Hill, K.; Hickman, R.; Bale, T.; Holle, B.; Mellinghoff, I.; Dunkel, I.; Souweidane, M.; Greenfield, J.; Sait, S. F.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • A novel oncogenic role for menin in glioma
    Meeting Abstract

    Yang, Y.; Saito, Y.; Goldberg, E.; Abou Mrad, Z.; Larsen, A. G.; Ghita, G.; Tabar, V.
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • INDIGO: A global, randomized, double-blinded, phase 3 study of vorasidenib versus placebo in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation
    Meeting Abstract

    Mellinghoff, I. K.; Van Den Bent, M. J.; Blumenthal, D. T.; Touat, M.; Peters, K. B.; Clarke, J. L.; Mendez, J. S.; Welsh, L.; Mason, W. P.; Hottinger, A. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries
    Journal Article

    Fernandez-Rozadilla, C.; Timofeeva, M.; Chen, Z.; Law, P.; Thomas, M.; Bien, S.; Díez-Obrero, V.; Hsu, L.; Fernandez-Tajes, J.; Palles, C.; more...
    Nature Genetics (2023)

    Fulltext@MSK | Save
  • Use of longitudinal functional MRI to demonstrate translocation of language function in patients with brain tumors
    Journal Article

    Quinones, A.; Jenabi, M.; Pasquini, L.; Peck, K. K.; Moss, N. S.; Brennan, C.; Tabar, V.; Holodny, A.
    Journal of Neurosurgery (2023)

    Fulltext@MSK | Save
  • Emerging therapies for breast cancer
    Review

    Goel, S.; Chandarlapaty, S.
    Cold Spring Harbor Perspectives in Medicine (2023)

    Fulltext@MSK | Save
  • Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer
    Journal Article

    Ricciuti, B.; Elkrief, A.; Alessi, J.; Wang, X.; Li, Y.; Gupta, H.; Muldoon, D. M.; Bertram, A. A.; Pecci, F.; Lamberti, G.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Distinct IDH1/2-associated methylation profile and enrichment of TP53 and TERT mutations distinguish dedifferentiated chondrosarcoma from conventional chondrosarcoma
    Journal Article

    Dermawan, J. K. T.; Nafa, K.; Mohanty, A.; Xu, Y.; Rijo, I.; Casanova, J.; Villafania, L.; Benhamida, J.; Kelly, C. M.; Tap, W. D.; more...
    Cancer Research Communications (2023)

    Fulltext@MSK | Save
  • Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms
    Journal Article

    Nannya, Y.; Tobiasson, M.; Sato, S.; Bernard, E.; Ohtake, S.; Takeda, J.; Creignou, M.; Zhao, L.; Kusakabe, M.; Shibata, Y.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • The treatment of aggressive prolactinomas with everolimus
    Journal Article

    Lin, A. L.; Geer, E. B.; Lala, N.; Page-Wilson, G.; Magge, R.; Young, R. J.; Tabar, V.
    Pituitary (2023)

    Fulltext@MSK | Save